Viamet Pharmaceuticals Holdings Llc
Durham, US · Founded 2011 · Delaware LLC · 1 known investors
Founders & leadership
NM
Neil MooreExecutive
RJ
Robert J. Schotzinger, M.D., Ph.D.Named on SEC filing
Board
SD
Steven D. WeinsteinBoard director
RI
KA
Kristopher A. WoodBoard director
AH
Adrian HowdBoard director
DR
Douglas ReedBoard director
SE
S. Edward TorresBoard director
WT
William T. White IIIBoard director
LS
Lauren SilvermanBoard director
JR
James RosenBoard director
AV
Andrew von EschenbachBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$61.6M disclosed across 3 rounds · 2011–2016
▶$12MraisedSep 2016 · 12 investors · OtherRule 506(b)
▶$12MraisedSep 2016 · 12 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Steven D. WeinsteinDirector
- Robert J. Schotzinger, M.D., Ph.D.Executive Officer, Director
- Robert IngramDirector
- Kristopher A. WoodDirector
- Adrian HowdDirector
- Andrew von EschenbachDirector
- Douglas ReedDirector
- Jeffrey EdwardsDirector
- G. Kelly MartinDirector
- S. Edward TorresDirector
- Philip R. TracyDirector
- Offering amount
- $48M
- Amount sold
- $12M
- First sale
- Sep 2016
- Incorporated
- Limited Liability Company, Delaware, 2011
- Federal exemptions
- 06b
▶$10MraisedMar 2014 · 7 investors · OtherRule 506(b)
▶$10MraisedMar 2014 · 7 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- S. Edward TorresDirector
- Neil MooreExecutive Officer
- Richard KatzExecutive Officer
- Kenneth BahkDirector
- James RosenDirector
- Robert J. Schotzinger, M.D., Ph.D.Executive Officer, Director
- Lauren SilvermanDirector
- Douglas ReedDirector
- Andrew von EschenbachDirector
- Offering amount
- $15M
- Amount sold
- $10M
- First sale
- Feb 2014
- Incorporated
- Limited Liability Company, Delaware, 2011
- Federal exemptions
- 06b
▶$39.6MraisedJan 2012 · 11 investors · OtherRule 506(b)
▶$39.6MraisedJan 2012 · 11 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Douglas ReedDirector
- Andrew von EschenbachDirector
- William T. White IIIDirector
- Lauren SilvermanDirector
- Neil MooreExecutive Officer
- Robert J. Schotzinger, M.D., Ph.D.Executive Officer, Director
- James RosenDirector
- S. Edward TorresDirector
- Offering amount
- $39.6M
- Amount sold
- $39.6M
- First sale
- Dec 2011
- Incorporated
- Limited Liability Company, Delaware, 2011
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Viamet Pharmaceuticals Holdings Llc's investors?
- Viamet Pharmaceuticals Holdings Llc's investors include Hatteras Venture Partners.
- How much funding has Viamet Pharmaceuticals Holdings Llc raised?
- Viamet Pharmaceuticals Holdings Llc has disclosed $61.6M raised across 3 rounds.
- Where is Viamet Pharmaceuticals Holdings Llc headquartered?
- Viamet Pharmaceuticals Holdings Llc is headquartered in Durham, US.